Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Clinical trial NCT05312879 · RECRUITING
Trial details
- NCT number
- NCT05312879
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-30
- Primary completion
- 2028-06-02
- Enrollment
- 466
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.